Methods of treating psoriasis with anti-TNF antibodies
US7192584B2 · kind B2 · utility
101Cited by
28References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 10, 2001 |
| Grant date | Mar 20, 2007 |
| Priority date | — |
| Expiry date | Sep 9, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to anti-TNF antibodies, fragments, regions and derivatives thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in methods of treating psoriasis, as well as polynucleotides coding for murine and chimeric anti-TNF antibodies, and methods of producing anti-TNF antibodies, fragments, regions and derivatives thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.